Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Andrea Schilz"'
Autor:
Andrea Schilz
Publikováno v:
Zeitschrift für digitale Geisteswissenschaften, Iss 003 (2021)
The article critically discusses the concept of ›the mass‹ from the perspective of crowdsourcing application fields. It provides, also considering historic aspects, an overview of specific methods used in the field of citizen science and in di
Externí odkaz:
https://doaj.org/article/53c59d97139c4e67b7a752192a497542
Autor:
Andrea Schilz, Malte Rehbein
Publikováno v:
Handbook Industry 4.0 ISBN: 9783662644478
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54d85e355acca481999dce7509ae9388
https://doi.org/10.1007/978-3-662-64448-5_64
https://doi.org/10.1007/978-3-662-64448-5_64
Autor:
Andrea Schilz, Malte Rehbein
Publikováno v:
Handbook Industry 4.0 ISBN: 9783662644478
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dccffff7f31afa1f546b51a45c87408
https://doi.org/10.1007/978-3-662-64448-5_63
https://doi.org/10.1007/978-3-662-64448-5_63
Autor:
Andrea Schilz, Malte Rehbein
Publikováno v:
Handbuch Industrie 4.0: Recht, Technik, Gesellschaft ISBN: 9783662584736
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17140426362d1119157e15a62d6d40f4
https://doi.org/10.1007/978-3-662-58474-3_75
https://doi.org/10.1007/978-3-662-58474-3_75
Autor:
Andrea Schilz, Malte Rehbein
Publikováno v:
Handbuch Industrie 4.0: Recht, Technik, Gesellschaft ISBN: 9783662584736
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56637c1cdc5a0a8775b523c6d5558fdd
https://doi.org/10.1007/978-3-662-58474-3_74
https://doi.org/10.1007/978-3-662-58474-3_74
Autor:
Andrea Schilz
A single abstract from the DHd-2017 Book of Abstracts.
Sofern eine editorische Arbeit an dieser Publikation stattgefunden hat, dann bestand diese aus der Eliminierung von Bindestrichen in Überschriften, die aufgrund fehlerhafter Silbentrennung
Sofern eine editorische Arbeit an dieser Publikation stattgefunden hat, dann bestand diese aus der Eliminierung von Bindestrichen in Überschriften, die aufgrund fehlerhafter Silbentrennung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9d7f8c5f086996d171688de70bdb79
Autor:
Andrea Brinkmann, Ursula Lüthi, Andrea Schilz, Nancy A. Jenkins, Claudia R. Ball, Manuel Grez, Christof von Kalle, Kerstin Schwarzwaelder, Neal G. Copeland, Dieter Hoelzer, Ulrich Siler, Annette Deichmann, Cynthia E. Dunbar, Hana Kunkel, Marlene Fischer, Ulrike Koehl, Adrian J. Thrasher, Moustapha Hassan, K. Kühlcke, Stefan Stein, Hanno Glimm, Manfred Schmidt, Reinhard Seger, Marion Ott, Yang Du, Sonja Naundorf, Ingo H. Pilz
Publikováno v:
Nature Medicine. 12:401-409
Gene transfer into hematopoietic stem cells has been used successfully for correcting lymphoid but not myeloid immunodeficiencies. Here we report on two adults who received gene therapy after nonmyeloablative bone marrow conditioning for the treatmen
Autor:
Klaus Kühlcke, Christopher Baum, Stephanie Laufs, Andrea Schilz, B. Schiedlmeier, Stefan Fruehauf, W. Jens Zeller, Eckert Hg
Publikováno v:
Human Gene Therapy. 13:233-242
Myelosuppression is the main side effect of cancer chemotherapy. An improved rate of retroviral vector-mediated gene transfer to hematopoietic stem cells, shown in more recent clinical trials, has created the basis to test the concept of myeloprotect
Autor:
C. Lindemann, Bernhard Schiedlmeier, Knipper R, Stefan Fruehauf, W. J. Zeller, Christopher Baum, Wolfram Ostertag, A A Fauser, Andrea Schilz, Eckert Hg, K. Kuehlcke, Markus Hildinger
Publikováno v:
Gene Therapy. 8:239-246
We describe the functional analysis of a novel retroviral vector, SF91m3, which was designed for improved expression of the in vivo selectable marker, multidrug resistance 1 gene (MDR1), in hematopoietic cells. SF91m3 combines several promising featu
Publikováno v:
The Journal of Gene Medicine. 3:427-436
Background For many inherited and acquired diseases of the blood system, gene transfer into hematopoietic cells is a promising strategy to alleviate disease-related symptoms or even correct genetic alterations. In clinical gene therapy applications,